148 related articles for article (PubMed ID: 18342015)
41. Large scale molecular dynamics simulation of native and mutant dihydropteroate synthase-sulphanilamide complexes suggests the molecular basis for dihydropteroate synthase drug resistance.
Giordanetto F; Fowler PW; Saqi M; Coveney PV
Philos Trans A Math Phys Eng Sci; 2005 Aug; 363(1833):2055-73. PubMed ID: 16099766
[TBL] [Abstract][Full Text] [Related]
42. Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: kinetic analysis of dihydropteroate synthases from N. meningitidis expressed in a knockout mutant of Escherichia coli.
Fermér C; Swedberg G
J Bacteriol; 1997 Feb; 179(3):831-7. PubMed ID: 9006040
[TBL] [Abstract][Full Text] [Related]
43. Sulfonamide resistance in clinical isolates of Campylobacter jejuni: mutational changes in the chromosomal dihydropteroate synthase.
Gibreel A; Sköld O
Antimicrob Agents Chemother; 1999 Sep; 43(9):2156-60. PubMed ID: 10471557
[TBL] [Abstract][Full Text] [Related]
44. Biosynthesis of tetrahydrofolate. Stereochemistry of dihydroneopterin aldolase.
Illarionova V; Eisenreich W; Fischer M; Haussmann C; Romisch W; Richter G; Bacher A
J Biol Chem; 2002 Aug; 277(32):28841-7. PubMed ID: 12039964
[TBL] [Abstract][Full Text] [Related]
45. Characterization of different plasmid-borne dihydropteroate synthases mediating bacterial resistance to sulfonamides.
Swedberg G; Sköld O
J Bacteriol; 1980 Apr; 142(1):1-7. PubMed ID: 6989796
[TBL] [Abstract][Full Text] [Related]
46. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases.
Wise EM; Abou-Donia MM
Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2621-5. PubMed ID: 1101260
[TBL] [Abstract][Full Text] [Related]
47. Toxoplasma gondii: characterization of a mutant resistant to sulfonamides.
Pfefferkorn ER; Borotz SE; Nothnagel RF
Exp Parasitol; 1992 May; 74(3):261-70. PubMed ID: 1582478
[TBL] [Abstract][Full Text] [Related]
48. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
[TBL] [Abstract][Full Text] [Related]
49. Fast reaction studies of the glycolytic pathway from aldolase to glyceraldehyde-3-phosphate dehydrogenase with physiological concentrations of enzymes: another oxygen-debt mechanism.
Hollaway MR; Dunn SM; Chapman PW
Biochem Soc Trans; 1987 Oct; 15(5):985-7. PubMed ID: 3691953
[No Abstract] [Full Text] [Related]
50. Insights into the drug resistance induced by the BaDHPS mutations: molecular dynamic simulations and MM/GBSA studies.
Chu WT; Zhang JL; Zheng QC; Chen L; Xue Q; Zhang HX
J Biomol Struct Dyn; 2013 Oct; 31(10):1127-36. PubMed ID: 23030549
[TBL] [Abstract][Full Text] [Related]
51. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme.
Lopez P; Espinosa M; Greenberg B; Lacks SA
J Bacteriol; 1987 Sep; 169(9):4320-6. PubMed ID: 3114239
[TBL] [Abstract][Full Text] [Related]
52. R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase.
Sköld O
Antimicrob Agents Chemother; 1976 Jan; 9(1):49-54. PubMed ID: 769673
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of pyrazolo-1,2,4-triazolo[4,3-a]quinoxalines as antimicrobial agents with potential inhibition of DHPS enzyme.
Z El-Attar MA; Elbayaa RY; Shaaban OG; Habib NS; Abdel Wahab AE; Abdelwahab IA; M El-Hawash SA
Future Med Chem; 2018 Sep; 10(18):2155-2175. PubMed ID: 30088415
[TBL] [Abstract][Full Text] [Related]
54. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis.
Aspinall TV; Joynson DH; Guy E; Hyde JE; Sims PF
J Infect Dis; 2002 Jun; 185(11):1637-43. PubMed ID: 12023770
[TBL] [Abstract][Full Text] [Related]
55. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
56. Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.
Pemble CW; Mehta PK; Mehra S; Li Z; Nourse A; Lee RE; White SW
PLoS One; 2010 Nov; 5(11):e14165. PubMed ID: 21152407
[TBL] [Abstract][Full Text] [Related]
57. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
de Beer TA; Louw AI; Joubert F
Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
[TBL] [Abstract][Full Text] [Related]
58. Structure and function of the dihydropteroate synthase from Staphylococcus aureus.
Hampele IC; D'Arcy A; Dale GE; Kostrewa D; Nielsen J; Oefner C; Page MG; Schönfeld HJ; Stüber D; Then RL
J Mol Biol; 1997 Apr; 268(1):21-30. PubMed ID: 9149138
[TBL] [Abstract][Full Text] [Related]
59. Effects of Osmolytes on Ligand Binding to Dihydropteroate Synthase from
Nambiar D; Sharma O; Duff MR; Howell EE
J Phys Chem B; 2020 Jul; 124(29):6212-6224. PubMed ID: 32580556
[TBL] [Abstract][Full Text] [Related]
60. Modulation of the interaction between aldolase and glycerol-phosphate dehydrogenase by fructose phosphates.
Vértessy BG; Orosz F; Ovádi J
Biochim Biophys Acta; 1991 Jun; 1078(2):236-42. PubMed ID: 2065091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
